Canada’s Leading Research Universities

Developing talent, Driving innovation, Delivering impact.

U of A virologist Matthias Götte was part of a research team that discovered a second way the antiviral drug remdesivir works against SARS-CoV-2, the virus that causes COVID-19. Götte says understanding how the drug works is key to developing further treatments against the virus. (Photo: Faculty of Medicine & Dentistry)

U of A lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir

Posted on

Understanding how the conditionally approved COVID-19 drug works is key to improving treatments, says researcher.

Researchers at the University of Alberta have discovered a novel, second mechanism of action by the antiviral drug remdesivir against SARS-CoV-2, according to findings published today in the Journal of Biological Chemistry….

https://www.folio.ca/u-of-a-lab-uncovers-new-mechanism-of-action-against-sars-cov-2-by-antiviral-drug-remdesivir/

Read More Impact Stories

Posted on

Spinal cord injury: stimulating neural plasticity to improve walking

This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Read more
Posted on

Unraveling the complexity of betacoronaviruses in bats

A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Read more
Posted on

Respiratory infections: better patient triage to relieve pressure on emergency departments

This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Read more
View All Impact Stories